FSLA President Virginia Clancy
FSLA Appoints New Leadership, Highlights Student Initiatives
September 19, 2024 13:22 ET | Florida Surplus Lines Association
TAMPA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The Florida Surplus Lines Association (FSLA), representing those providing solutions as a safety valve for Florida's insurance industry, installed its new...
Company logo.png
Pharmazz Inc. announces that Dr. Neil Marwah has joined the Company as its President
September 11, 2024 07:00 ET | Pharmazz, Inc.
Pharmazz Inc. announces that Dr. Neil Marwah has joined the Company as its President.
James (Josh) Wilson Faruqi & Faruqi, LLP
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of American Airlines
September 06, 2024 10:52 ET | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In American Airlines To Contact Him Directly To Discuss Their...
James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of American Airlines
August 22, 2024 17:10 ET | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In American Airlines To Contact Him Directly To Discuss Their...
niba-logo.jpg
NIBA to Host 150th Investment Conference in Florida from Sept. 4-5, 2024
August 22, 2024 09:35 ET | The National Investment Banking Association
FORT LAUDERDALE, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- via InvestorWire -- The National Investment Banking Association (“NIBA”) announces today it will host its 150th Investment Conference on...
Company logo.png
Pharmazz Inc. and Sun Pharma entered into an agreement under which Sun Pharma will invest up to $15 Million in Pharmazz, Inc.
August 21, 2024 07:00 ET | Pharmazz, Inc.
Pharmazz Inc. and Sun Pharma entered into an agreement under which Sun Pharma will invest up to $15 Million in Pharmazz, Inc.
Bioxodes annonce la
Bioxodes annonce la recommandation positive du DMC pour son essai de phase 2a dans le traitement des AVC hémorragiques avec BIOX-101
August 21, 2024 02:30 ET | Bioxodes
 Le Comité de surveillance des données (DMC, Data Monitoring Committee) a recommandé la poursuite de l’étude après l’examen planifié des données provenant des 8 premiers patients  L’analyse des...
Bioxodes reports pos
Bioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic stroke
August 21, 2024 02:30 ET | Bioxodes
 Planned Data Monitoring Committee (DMC) meeting recommended continuation of the study after reviewing data from the first 8 patients  Interim data from 16 patients scheduled around the end of 2024 ...
PanOmiQ
PanOmiQ Set’s New Benchmark with 100% Accuracy in Whole Genome Sequencing Testing
August 20, 2024 09:48 ET | BioAro
BioAro's PanOmiQ achieves 100% accuracy in Whole Genome Sequencing, setting a new benchmark; a 15-day free trial of AI-powered software is now available.
ibn_169.jpg
IBN Selected as Official Media Sponsor for NIBA’s 150th Investment Conference
August 20, 2024 09:35 ET | InvestorBrandNetwork (IBN)
NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (“InvestorBrandNetwork”), a cutting-edge corporate communications and digital engagement platform providing tailored platform...